During the past decade, Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes" are "Autoimmune Encephalitis" (4 trials), "Paraneoplastic Syndromes" (2 trials), "Anti-LGI1 Encephalitis" (1 trials), "Autoimmune Cerebellar Ataxia" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes" in a lesser frequency.

Most popular intervention types in "Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes" are "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma." (1 trials), "Diagnosis test" (1 trials) and "GWAS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".